α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals

Jianhua Xu, Xin Sheng Wu, Jiansong Sheng, Zhen Zhang, Hai Yuan Yue, Lixin Sun, Carmelo Sgobio, Xian Lin, Shiyong Peng, Yinghui Jin, Lin Gan, Huaibin Cai, Ling Gang Wu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

α-Synuclein (α-syn) missense and multiplication mutations have been suggested to cause neurodegenerative diseases, including Parkinson's disease (PD) and dementia with Lewy bodies. Before causing the progressive neuronal loss, α-syn mutations impair exocytosis, which may contribute to eventual neurodegeneration. To understand how α-syn mutations impair exocytosis, we developed a mouse model that selectively expressed PD-related human α-syn A53T (h-α-synA53T) mutation at the calyx of Held terminals, where release mechanisms can be dissected with a patch-clamping technique. With capacitance measurement of endocytosis, we reported that h-α-synA53T, either expressed transgenically or dialyzed in the short term in calyces, inhibited two of the most common forms of endocytosis, the slow and rapid vesicle endocytosis at mammalian central synapses. The expression of h-α-synA53T in calyces also inhibited vesicle replenishment to the readily releasable pool. These findings may help to understand how α-syn mutations impair neurotransmission before neurodegeneration. SIGNIFICANCE STATEMENT α-Synuclein (α-syn) missense or multiplication mutations may cause neurodegenerative diseases, such as Parkinson's disease and dementia with Lewy bodies. The initial impact of α-syn mutations before neuronal loss is impairment of exocytosis, which may contribute to eventual neurodegeneration. The mechanism underlying impairment of exocytosis is poorly understood. Here we report that an α-syn mutant, the human α-syn A53T, inhibited two of the most commonly observed forms of endocytosis, slow and rapid endocytosis, at a mammalian central synapse. We also found that α-syn A53T inhibited vesicle replenishment to the readily releasable pool. These results may contribute to accounting for the widely observed early synaptic impairment caused by α-syn mutations in the progression toward neurodegeneration.

Original languageEnglish (US)
Pages (from-to)4408-4414
Number of pages7
JournalJournal of Neuroscience
Volume36
Issue number16
DOIs
StatePublished - Apr 20 2016

Fingerprint

Synucleins
Endocytosis
Exocytosis
Mutation
Parkinson Disease
Lewy Body Disease
Neurodegenerative Diseases
Synapses
Missense Mutation
Constriction
Synaptic Transmission

Keywords

  • Endocytosis
  • Nerve terminal
  • Parkinson’s disease
  • Transmitter
  • Vesicle
  • α-synuclein

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Xu, J., Wu, X. S., Sheng, J., Zhang, Z., Yue, H. Y., Sun, L., ... Wu, L. G. (2016). α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals. Journal of Neuroscience, 36(16), 4408-4414. https://doi.org/10.1523/JNEUROSCI.3627-15.2016

α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals. / Xu, Jianhua; Wu, Xin Sheng; Sheng, Jiansong; Zhang, Zhen; Yue, Hai Yuan; Sun, Lixin; Sgobio, Carmelo; Lin, Xian; Peng, Shiyong; Jin, Yinghui; Gan, Lin; Cai, Huaibin; Wu, Ling Gang.

In: Journal of Neuroscience, Vol. 36, No. 16, 20.04.2016, p. 4408-4414.

Research output: Contribution to journalArticle

Xu, J, Wu, XS, Sheng, J, Zhang, Z, Yue, HY, Sun, L, Sgobio, C, Lin, X, Peng, S, Jin, Y, Gan, L, Cai, H & Wu, LG 2016, 'α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals', Journal of Neuroscience, vol. 36, no. 16, pp. 4408-4414. https://doi.org/10.1523/JNEUROSCI.3627-15.2016
Xu, Jianhua ; Wu, Xin Sheng ; Sheng, Jiansong ; Zhang, Zhen ; Yue, Hai Yuan ; Sun, Lixin ; Sgobio, Carmelo ; Lin, Xian ; Peng, Shiyong ; Jin, Yinghui ; Gan, Lin ; Cai, Huaibin ; Wu, Ling Gang. / α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals. In: Journal of Neuroscience. 2016 ; Vol. 36, No. 16. pp. 4408-4414.
@article{26ca6b05b85f4261b2dff1d9bd903188,
title = "α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals",
abstract = "α-Synuclein (α-syn) missense and multiplication mutations have been suggested to cause neurodegenerative diseases, including Parkinson's disease (PD) and dementia with Lewy bodies. Before causing the progressive neuronal loss, α-syn mutations impair exocytosis, which may contribute to eventual neurodegeneration. To understand how α-syn mutations impair exocytosis, we developed a mouse model that selectively expressed PD-related human α-syn A53T (h-α-synA53T) mutation at the calyx of Held terminals, where release mechanisms can be dissected with a patch-clamping technique. With capacitance measurement of endocytosis, we reported that h-α-synA53T, either expressed transgenically or dialyzed in the short term in calyces, inhibited two of the most common forms of endocytosis, the slow and rapid vesicle endocytosis at mammalian central synapses. The expression of h-α-synA53T in calyces also inhibited vesicle replenishment to the readily releasable pool. These findings may help to understand how α-syn mutations impair neurotransmission before neurodegeneration. SIGNIFICANCE STATEMENT α-Synuclein (α-syn) missense or multiplication mutations may cause neurodegenerative diseases, such as Parkinson's disease and dementia with Lewy bodies. The initial impact of α-syn mutations before neuronal loss is impairment of exocytosis, which may contribute to eventual neurodegeneration. The mechanism underlying impairment of exocytosis is poorly understood. Here we report that an α-syn mutant, the human α-syn A53T, inhibited two of the most commonly observed forms of endocytosis, slow and rapid endocytosis, at a mammalian central synapse. We also found that α-syn A53T inhibited vesicle replenishment to the readily releasable pool. These results may contribute to accounting for the widely observed early synaptic impairment caused by α-syn mutations in the progression toward neurodegeneration.",
keywords = "Endocytosis, Nerve terminal, Parkinson’s disease, Transmitter, Vesicle, α-synuclein",
author = "Jianhua Xu and Wu, {Xin Sheng} and Jiansong Sheng and Zhen Zhang and Yue, {Hai Yuan} and Lixin Sun and Carmelo Sgobio and Xian Lin and Shiyong Peng and Yinghui Jin and Lin Gan and Huaibin Cai and Wu, {Ling Gang}",
year = "2016",
month = "4",
day = "20",
doi = "10.1523/JNEUROSCI.3627-15.2016",
language = "English (US)",
volume = "36",
pages = "4408--4414",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "16",

}

TY - JOUR

T1 - α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals

AU - Xu, Jianhua

AU - Wu, Xin Sheng

AU - Sheng, Jiansong

AU - Zhang, Zhen

AU - Yue, Hai Yuan

AU - Sun, Lixin

AU - Sgobio, Carmelo

AU - Lin, Xian

AU - Peng, Shiyong

AU - Jin, Yinghui

AU - Gan, Lin

AU - Cai, Huaibin

AU - Wu, Ling Gang

PY - 2016/4/20

Y1 - 2016/4/20

N2 - α-Synuclein (α-syn) missense and multiplication mutations have been suggested to cause neurodegenerative diseases, including Parkinson's disease (PD) and dementia with Lewy bodies. Before causing the progressive neuronal loss, α-syn mutations impair exocytosis, which may contribute to eventual neurodegeneration. To understand how α-syn mutations impair exocytosis, we developed a mouse model that selectively expressed PD-related human α-syn A53T (h-α-synA53T) mutation at the calyx of Held terminals, where release mechanisms can be dissected with a patch-clamping technique. With capacitance measurement of endocytosis, we reported that h-α-synA53T, either expressed transgenically or dialyzed in the short term in calyces, inhibited two of the most common forms of endocytosis, the slow and rapid vesicle endocytosis at mammalian central synapses. The expression of h-α-synA53T in calyces also inhibited vesicle replenishment to the readily releasable pool. These findings may help to understand how α-syn mutations impair neurotransmission before neurodegeneration. SIGNIFICANCE STATEMENT α-Synuclein (α-syn) missense or multiplication mutations may cause neurodegenerative diseases, such as Parkinson's disease and dementia with Lewy bodies. The initial impact of α-syn mutations before neuronal loss is impairment of exocytosis, which may contribute to eventual neurodegeneration. The mechanism underlying impairment of exocytosis is poorly understood. Here we report that an α-syn mutant, the human α-syn A53T, inhibited two of the most commonly observed forms of endocytosis, slow and rapid endocytosis, at a mammalian central synapse. We also found that α-syn A53T inhibited vesicle replenishment to the readily releasable pool. These results may contribute to accounting for the widely observed early synaptic impairment caused by α-syn mutations in the progression toward neurodegeneration.

AB - α-Synuclein (α-syn) missense and multiplication mutations have been suggested to cause neurodegenerative diseases, including Parkinson's disease (PD) and dementia with Lewy bodies. Before causing the progressive neuronal loss, α-syn mutations impair exocytosis, which may contribute to eventual neurodegeneration. To understand how α-syn mutations impair exocytosis, we developed a mouse model that selectively expressed PD-related human α-syn A53T (h-α-synA53T) mutation at the calyx of Held terminals, where release mechanisms can be dissected with a patch-clamping technique. With capacitance measurement of endocytosis, we reported that h-α-synA53T, either expressed transgenically or dialyzed in the short term in calyces, inhibited two of the most common forms of endocytosis, the slow and rapid vesicle endocytosis at mammalian central synapses. The expression of h-α-synA53T in calyces also inhibited vesicle replenishment to the readily releasable pool. These findings may help to understand how α-syn mutations impair neurotransmission before neurodegeneration. SIGNIFICANCE STATEMENT α-Synuclein (α-syn) missense or multiplication mutations may cause neurodegenerative diseases, such as Parkinson's disease and dementia with Lewy bodies. The initial impact of α-syn mutations before neuronal loss is impairment of exocytosis, which may contribute to eventual neurodegeneration. The mechanism underlying impairment of exocytosis is poorly understood. Here we report that an α-syn mutant, the human α-syn A53T, inhibited two of the most commonly observed forms of endocytosis, slow and rapid endocytosis, at a mammalian central synapse. We also found that α-syn A53T inhibited vesicle replenishment to the readily releasable pool. These results may contribute to accounting for the widely observed early synaptic impairment caused by α-syn mutations in the progression toward neurodegeneration.

KW - Endocytosis

KW - Nerve terminal

KW - Parkinson’s disease

KW - Transmitter

KW - Vesicle

KW - α-synuclein

UR - http://www.scopus.com/inward/record.url?scp=84964068290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964068290&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3627-15.2016

DO - 10.1523/JNEUROSCI.3627-15.2016

M3 - Article

C2 - 27098685

AN - SCOPUS:84964068290

VL - 36

SP - 4408

EP - 4414

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 16

ER -